4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001960048-26-000004
SVP, Finance & CAO sold 2,500 shares at $58.59 ($146,482)
- SVP, Finance & CAO acquired 2,500 shares (option exercise)
- SVP, Finance & CAO gave up 495 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cowan Elvia SVP, Finance & CAO | 2026-03-09 | Shares withheld for taxes 10b5-1 | −495 | $59.32 | $29,363 | 30,867 | D |
| Cowan Elvia SVP, Finance & CAO | 2026-03-11 | Option exercise 10b5-1 | +2,500 | $25.92 | $64,800 | 33,367 | D |
| Cowan Elvia SVP, Finance & CAO | 2026-03-11 | Sale 10b5-1 | −2,500 | $58.59 | $146,482 | 30,867 | D |
| Derivatives | |||||||
| Cowan Elvia SVP, Finance & CAO | 2026-03-11 | Option exercise · Stock Option (right to buy) 10b5-1 | −2,500 | 96,068 | D | ||
| Open-market sales · 2,500 sh · avg $58.59 · $146,482 | |||||||
Loading xslF345X05/wk-form4_1773264233.xml…